Cyclerion Therapeutics, Inc. Common Stock (NASDAQ: CYCN) last traded at $3.89, down 4.42% on the session. The quote above updates while this page is open; the figures below are drawn from Cyclerion Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cyclerion Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CYCN. Its market capitalisation is $18.21 million.
Valuation measures for Cyclerion Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $18.21M |
|---|---|
| Price / sales | 9.14 |
| Price / book | 3.58 |
| Beta | 2.13 |
Trailing-twelve-month figures tagged in Cyclerion Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.99M |
|---|---|
| Net income (TTM) | -$6.71M |
| EPS (TTM) | -$1.61 |
| Operating margin | -342.40% |
| Return on equity | -131.85% |
| Cash | $1.39M |
Range and volume for CYCN over the past 52 weeks.
| 52-week high | $8.48 |
|---|---|
| 52-week low | $1.03 |
| Volume | 64.5K |
| Average volume | 27.2K |
| Previous close | $4.07 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.